Over the years the number of Xarelto lawsuits filed has increased by a great extent in the United States. And now there are many plaintiffs who are seeking compensation for all the damage they had to suffer, even in Canada as well. Xarelto, also known as Rivaroxaban, is a blood thinning drug that was introduced by the company Bayer AG and Janssen Pharmaceutical. The new blood thinner was introduced to the market as a means of replacing an older anticoagulant drug, Warfarin. This drug needed to be constantly monitored plus patients who took this drug had to follow a serious diet plan that restricted them from eating most of the food items. Whereas rivaroxaban was said to be a better option compared to the older drug, since it required no such limitations and was considered to be a safer option.
But is this drug really a safer option?
However, this drug has no antidote that would allow you to reverse the effects it seems to give cause. According to claims the drug has resulted in people suffering from severe uncontrollable bleeding, and many patients have died. Patients who have suffered due to this drug, or people who lost their loved ones due to the use of this drug, have been demanding pharmaceutical companies to pay the expenses that they had to suffer as a compensation for all the damage that this drug has caused. People have filed cases against these companies demanding their rights and asking them to pay for all the damage that they had to go through. This has been happening not only in American but now even Canadian citizens have started filling cases against the company Bayer and Janssen. Now the number of lawsuits that have been filed against the company seems to have doubled and keep on increasing.
Lawsuits that are being filed against the company
The first ever Canadian Xarelto Lawsuit that was filed against the company was in February 2016, in Calgary. And now another lawsuit is soon to be filed in Ontario as well. The lawsuit was filed by a Canadian woman who had taken the drug in order to treat her atrial fibrillation but ended up suffering from severe internal bleeding which caused her to suffer from a heart attack as well. The physicians tried their hardest to stop her hemorrhaging, but this proved to be extremely difficult since they had no antidote to control the bleeding. This caused a huge impact on her cardiovascular health as well. Not only that but the Canadian regulatory agency equivalent of FDA, Health Canada, have received over thousands of reports from various patients complaining about the severe damage they have suffered due to the drug. And many of these reports also included deaths as well. The Ontario lawsuit is expected to be filed by an 83-year-old woman who passed away in November 2013, due to internal bleeding that was caused by the use of this drug. Her family is seeking compensation for all the pain they had to go through and they wish to let it be known how dangerous this drug actually is.